Skip to main content
See every side of every news story
Published loading...Updated

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors (NYSE:ASPN)

Q2 revenue topped guidance as thermal barrier sales recovered and the company lowered its annual EBITDA break-even threshold to $175 million, analysts said.

Summary
Aspen Aerogels stock is a "Hold" but its Q3 outlook shows recovery as revenues/EBITDA improve and break-even drops. Click here to learn more about ASPN.

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel on Monday, August 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal